Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 15262-86-9
2. Chebi:35001
3. X8st05gydm
4. [(8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 4-methylpentanoate
5. Testosterone Isocapronate
6. Chembl3189011
7. 17beta-hydroxyandrost-4-ene-3-one 4-methylvalerate
8. Nsc-26641
9. Androst-4-en-3-one, 17-[(4-methyl-1-oxopentyl)oxy]-, (17b)-
10. (8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl 4-methylpentanoate
11. Unii-x8st05gydm
12. Testosterone, 17-(4-methylvalerate)
13. Ncgc00181019-01
14. Einecs 239-307-1
15. Nsc 26641
16. Dsstox_cid_26806
17. Dsstox_rid_81920
18. Dsstox_gsid_46806
19. Testosterone 4-methylvalerate
20. Testosterone, 17-isocaproate
21. Schembl354423
22. Gtpl7629
23. Dtxsid0046806
24. Nsc26641
25. Zinc4538407
26. Tox21_112669
27. Androst-4-en-3-one, 17-((4-methyl-1-oxopentyl)oxy)-, (17beta)-
28. Androst-4-en-3-one, 17-[(4-methyl-1-oxopentyl)oxy]-, (17.beta.)-
29. Bdbm50103618
30. Mfcd00133848
31. Akos015901952
32. Testosterone, 17-(4-methylpentanoate)
33. Testosterone Isocaproate [mart.]
34. Testosterone Isocaproate [who-dd]
35. Ds-11482
36. Cas-15262-86-9
37. Testosterone Isocaproate, Analytical Standard
38. Testosterone Isocaproate For System Suitability
39. D97820
40. Testosterone Isocaproate [ep Monograph]
41. Testosterone Isocaproate--dea*schedule Iii Item
42. 262t869
43. A809335
44. Testosterone Isocaproate 1.0 Mg/ml In Acetonitrile
45. W-108049
46. Androst-4-en-3-one, 17-(4-methyl-1-oxopentyloxy]-
47. Q21099574
48. 3-oxoandrost-4-en-17.beta.-yl 4-methylpentanoate
49. 17.beta.-hydroxyandrost-4-en-3-one 4-methylpentanoate
50. 2-(1-imidazoylsulfonyl)-1,3,5-tri-o-benzoyl-alpha-d-ribofuranose
51. Testosterone Isocaproate, European Pharmacopoeia (ep) Reference Standard
52. [(8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxidanylidene-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 4-methylpentanoate
53. 4-methylpentanoic Acid [(8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] Ester
54. Testosterone Isocaproate For System Suitability, European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 386.6 g/mol |
---|---|
Molecular Formula | C25H38O3 |
XLogP3 | 5.5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 386.28209507 g/mol |
Monoisotopic Mass | 386.28209507 g/mol |
Topological Polar Surface Area | 43.4 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 677 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Testosterone Isocaproate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Testosterone Isocaproate, including repackagers and relabelers. The FDA regulates Testosterone Isocaproate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Testosterone Isocaproate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Testosterone Isocaproate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Testosterone Isocaproate supplier is an individual or a company that provides Testosterone Isocaproate active pharmaceutical ingredient (API) or Testosterone Isocaproate finished formulations upon request. The Testosterone Isocaproate suppliers may include Testosterone Isocaproate API manufacturers, exporters, distributors and traders.
click here to find a list of Testosterone Isocaproate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Testosterone Isocaproate CEP of the European Pharmacopoeia monograph is often referred to as a Testosterone Isocaproate Certificate of Suitability (COS). The purpose of a Testosterone Isocaproate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Testosterone Isocaproate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Testosterone Isocaproate to their clients by showing that a Testosterone Isocaproate CEP has been issued for it. The manufacturer submits a Testosterone Isocaproate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Testosterone Isocaproate CEP holder for the record. Additionally, the data presented in the Testosterone Isocaproate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Testosterone Isocaproate DMF.
A Testosterone Isocaproate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Testosterone Isocaproate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Testosterone Isocaproate suppliers with CEP (COS) on PharmaCompass.
A Testosterone Isocaproate written confirmation (Testosterone Isocaproate WC) is an official document issued by a regulatory agency to a Testosterone Isocaproate manufacturer, verifying that the manufacturing facility of a Testosterone Isocaproate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Testosterone Isocaproate APIs or Testosterone Isocaproate finished pharmaceutical products to another nation, regulatory agencies frequently require a Testosterone Isocaproate WC (written confirmation) as part of the regulatory process.
click here to find a list of Testosterone Isocaproate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Testosterone Isocaproate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Testosterone Isocaproate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Testosterone Isocaproate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Testosterone Isocaproate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Testosterone Isocaproate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Testosterone Isocaproate suppliers with NDC on PharmaCompass.
Testosterone Isocaproate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Testosterone Isocaproate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Testosterone Isocaproate GMP manufacturer or Testosterone Isocaproate GMP API supplier for your needs.
A Testosterone Isocaproate CoA (Certificate of Analysis) is a formal document that attests to Testosterone Isocaproate's compliance with Testosterone Isocaproate specifications and serves as a tool for batch-level quality control.
Testosterone Isocaproate CoA mostly includes findings from lab analyses of a specific batch. For each Testosterone Isocaproate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Testosterone Isocaproate may be tested according to a variety of international standards, such as European Pharmacopoeia (Testosterone Isocaproate EP), Testosterone Isocaproate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Testosterone Isocaproate USP).
LOOKING FOR A SUPPLIER?